Biomimetic Nanoemulsion for Synergistic Photodynamic‐Immunotherapy Against Hypoxic Breast Tumor-Reference-Cited by-同舟云学术

Biomimetic Nanoemulsion for Synergistic Photodynamic‐Immunotherapy Against Hypoxic Breast Tumor

Published:2021-03-18 Issue:19 Volume:133 Page:10742-10748
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angew. Chem.

Author:

Zhang Yifan¹,Liao Yunyan¹,Tang Qinan¹,Lin Jing¹,Huang Peng¹^ORCID

Affiliation:

1. Marshall Laboratory of Biomedical Engineering International Cancer Center Laboratory of Evolutionary Theranostics (LET) School of Biomedical Engineering Shenzhen University Health Science Center Shenzhen 518060 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202015590

Reference54 articles.

1. The future of immune checkpoint therapy

2. Cancer immunotherapy using checkpoint blockade

3. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

4. Innate and adaptive immune cells in the tumor microenvironment

5. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoimmunotherapy for cancer treatment based on organic small molecules: Recent strategies and future directions;Translational Oncology;2024-11

2. Recent advances in biomimetic cell membrane–camouflaged nanoparticles for cancer therapy;Biomedicine & Pharmacotherapy;2024-08

3. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01

4. Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy;Advanced Healthcare Materials;2023-05-10

5. Integrated Nanorod‐Mediated PD‐L1 Downregulation in Combination with Oxidative‐Stress Immunogene Therapy against Cancer;Advanced Healthcare Materials;2023-02-22